Chronic Heart Failure with Iron Deficiency
This study investigates if correcting iron deficiency in patients with chronic heart failure can improve their overall resilience and potentially reduce hospitalizations caused by various health problems.
Qualification Requirements
- Men and Women
- Age 18 years or older (≥18 years)
- Documented medical history of Chronic Heart Failure
- Recent Hemoglobin level at or below 13 g/dL (for women) or at or below 14 g/dL (for men)
COMPENSATION UP TO: TBD
Study Details
This clinical research trial explores the important connection between iron levels and outcomes in individuals living with Chronic Heart Failure (CHF). Iron deficiency is common in CHF patients and may contribute to symptoms like fatigue and reduced exercise capacity, potentially increasing vulnerability to complications. The primary objective of this study is to determine if treating this iron deficiency can strengthen patients' ability to cope with health challenges and consequently reduce the frequency of hospital admissions.
Enrollment is open to adult men and women aged 18 years and older who have a confirmed medical diagnosis of Chronic Heart Failure. A key requirement for participation is evidence of iron deficiency, specifically indicated by recent blood test results showing a hemoglobin level of 13 g/dL or lower for women, or 14 g/dL or lower for men. These criteria ensure the study focuses on the specific patient group hypothesized to benefit most from iron correction therapy.